Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nasdaq

What's Going On With FreightCar America Shares Today

FreightCar America, Inc. (NASDAQ:RAIL) reported first-quarter revenue growth of 188% year-over-year to $93.2 million, beating the consensus of $71.3 million. The company delivered 783 railcars in Q1 versus 309 railcars in Q1 2020. The gross margin for the quarter was 10.8%, up by 672 bps. The operating loss narrowed to $(0.655) million…

Benzinga

Cyclacel Pharmaceuticals's Earnings Outlook

Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to know before the announcement. Analysts estimate that Cyclacel Pharmaceuticals will report an earnings per share (EPS) of $-0.68.

Benzinga

What Are Whales Doing With SoFi Technologies

A whale with a lot of money to spend has taken a noticeably bearish stance on SoFi Technologies. Looking at options history for SoFi Technologies (NASDAQ:SOFI) we detected 21 strange trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

B. Riley Securities Maintains Buy Rating for Ballard Power Systems: Here's What You Need To Know

B. Riley Securities has decided to maintain its Buy rating of Ballard Power Systems (NASDAQ:BLDP) and lower its price target from $15.00 to $12.00. Shares of Ballard Power Systems are trading down 5.71% over the last 24 hours, at $6.53 per share.

Benzinga

Credit Suisse Maintains Neutral Rating for Groupon: Here's What You Need To Know

Credit Suisse has decided to maintain its Neutral rating of Groupon (NASDAQ:GRPN) and lower its price target from $29.00 to $23.00. Shares of Groupon are trading down 10.15% over the last 24 hours, at $14.07 per share. A move to $23.00 would account for a 63.47% increase from the current…

Benzinga

Citigroup Maintains Buy Rating for Ultragenyx Pharmaceutical: Here's What You Need To Know

Citigroup has decided to maintain its Buy rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) and lower its price target from $150.00 to $146.00. Shares of Ultragenyx Pharmaceutical are trading up 2.9% over the last 24 hours, at $53.30 per share.

Benzinga

Morgan Stanley Maintains Overweight Rating for Global E Online: Here's What You Need To Know

Morgan Stanley has decided to maintain its Overweight rating of Global E Online (NASDAQ:GLBE) and lower its price target from $70.00 to $48.00. Shares of Global E Online are trading down 8.99% over the last 24 hours, at $18.01 per share.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Nomura Instinet Upgrades Goodyear Tire & Rubber: Here's What You Need To Know

Nomura Instinet upgraded its rating of Goodyear Tire & Rubber (NASDAQ:GT) to Buy with a price target of $15.30, changing its price target from $15.00 to $15.30. Shares of Goodyear Tire & Rubber are trading up 0.13% over the last 24 hours, at $11.38 per share.

Benzinga

Here's Why AdaptHealth Shares Are Soaring Today

AdaptHealth Corp (NASDAQ: AHCO) says it delivered solid Q1 net revenue and Adjusted EBITDA as it began to overcome ongoing challenges resulting from shortages of CPAP equipment.

Benzinga

Costco Wholesale Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Costco Wholesale (NASDAQ:COST). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Why Bitcoin-, Ethereum- And Litecoin-Related Stock Coinbase Is Diving Today

Shares of several banks and financial services companies, including Coinbase Global Inc (NASDAQ: COIN), are trading lower amid continued volatility as traders assess recent Fed policy changes and ongoing inflation concerns.

Benzinga

Arrival Pushes Forward Towards Start Of Production In Q3; Loss Narrows In Q1

Arrival SA (NASDAQ:ARVL) reported a first-quarter FY22 loss of $(10.4) million versus a loss of $(1.15) billion last year that included a $1.2 billion non-cash charge associated with the merger of Arrival and CIIG. The adjusted EBITDA loss for the quarter widened to $(66.9) million. Capital expenditure rose 99% Y/Y to $99.1 million.…

Benzinga

Amid Baby Formula Shortage, Retailers Put Cap On Purchases: Report

The U.S. faced a nationwide shortage of the most popular baby formula brands in the week starting April 24, according to the latest figures from Datasembly, which tracks out-of-stock messages on retailers' websites and apps. An average rate is less than 10%. Reasons For The Shortage: Supply chain issues caused by the COVID-19…

Benzinga

Here's Why SmileDirectClub Shares Are Getting Hammered Today

SmileDirectClub Inc (NASDAQ: SDC) shares are trading lower by 15.81% at $1.27 after the company reported worse-than-expected first-quarter EPS results.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Mid-Day Market Update: U.S. Stocks Turn Lower; Biohaven Pharmaceutical Shares Jump

U.S. stocks turned mostly lower midway through trading, with the Dow Jones dropping more than 100 points on Tuesday.

Benzinga

Short Volatility Alert: Better World Acquisition Corp

On Monday, shares of Better World Acquisition Corp. (NASDAQ: BWAC) experienced volatile short activity. After the activity, the stock price moved down -0.10% to $10.29. The overall sentiment for BWAC has been Bullish.

Benzinga

iPhone Pioneer Shares Interesting Model From Steve Jobs Era That Didn't See Daylight

Apple, Inc.'s (NASDAQ: AAPL) iPod, a revolutionary product among portable music players, reportedly served as an inspiration for one of the earliest prototypes of the company's flagship iPhone.

Benzinga

Why Is Dave Chappelle's Stand-Up Not Included In Netflix's Upcoming Comedy Specials?

Netflix Inc (NASDAQ: NFLX) will not include Dave Chappelle’s segment in the streaming version of its recent comedy festival, but the exclusion is not based on the assault that occurred while Chappelle was in performance.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

77 Stocks Moving In Tuesday's Mid-Day Session

Gainers

Benzinga

Ecstasy Research Trial Completes Enrollment, Moves Closer To Approval To Treat PTSD

The non-profit Multidisciplinary Association for Psychedelics Studies (MAPS) and its subsidiary MAPS Public Benefit Corporation finished the enrollment stage for the second Phase 3 clinical trial on MDMA (MAPP2).

Benzinga

BofA Upgrades O'Reilly After A Relook At Q1 Print

O'Reilly Automotive Inc (NASDAQ: ORLY) is a defensive auto-parts retailer whose stock has moved significantly lower, according to BofA Securities.

Benzinga

Stodgy Tax Services IPO Looks Like What U.S. Investors Want from China Now

Key Takeaways: Lichen China has filed for an IPO to raise about $25 million, positioning itself as a potential consolidator in China’s vast, but highly fragmented, tax services market Company points out it should be able to avoid many of the recent controversies now dogging U.S.-listed Chinese stocks By Doug…

Benzinga

Why This Analyst Remains Bullish On Upstart Holdings, While Others Cut Their Ratings

Upstart Holdings Inc (NASDAQ: UPST) reported better-than-expected first-quarter results on Monday after the bell. However, shares of the AI consumer lending company tumbled more than 40% as management slashed the 2022 revenue forecast to $1.25 billion.

Benzinga

Vertex Energy Clocks 61% Top-Line Growth In Q1

Vertex Energy Inc (NASDAQ:VTNR) reported first-quarter revenue growth of 60.6% year-over-year to $40.22 million, missing the consensus of $51.69 million. EPS loss was $(0.08) compared to $0.01 a year ago. The gross margin contracted by 466 bps to 3.8%. Vertex's operating loss increased to $(7.27) million from $(0.76) million a year ago.…

Benzinga

Why Vroom Shares Are Racing Higher Today

Vroom Inc (NASDAQ: VRM) shares are trading higher Tuesday after the company announced better-than-expected financial results.

1 … 438 439 440 441

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.